Galectin Therapeutics GALT
NASDAQ GALT
$3.90 +0.14 (+3.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Change in Accured Expenses (2010 - 2026)

Updated

Galectin Therapeutics' Change in Accured Expenses was $1.85 million in Q2 2026, compared with -$4.64 million a year earlier and up 0.9% from the prior quarter.

Analysis

Galectin Therapeutics (GALT) Change in Accured Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Galectin Therapeutics' Change in Accured Expenses was $13.15 million through Jun 30, 2026; for FY2025, it was $6.24 million, up 40.4% from FY2024.

  • Change in Accured Expenses shows a five-year compound annual growth rate of 19.7% (FY2020 to FY2025).
  • In earlier years, Change in Accured Expenses was $4.44 million in FY2024 (+66.2%), $2.67 million in FY2023 (-37.1%), $4.24 million in FY2022 (+15.1%) and $3.69 million in FY2021 (+45.3%).
  • Quarterly Change in Accured Expenses has moved between -$4.64 million (Q2 2025) and $7.72 million (Q3 2025) over five years.
  • Compared with a year earlier, Change in Accured Expenses was higher in four of the last five quarters, with growth averaging 124.3%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q3 2025 (growth of 541.6%); the worst was Q4 2021 (a decline of 76.4%).
  • Per Business Quant data, GALT's Change in Accured Expenses in the three quarters before Q2 2026 was $1.83 million (Q1 2026), $1.76 million (Q4 2025) and $7.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Galectin Therapeutics 258.62 Mn 258.62 Mn - 1.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.85 Mn
Mar 31, 2026 1.83 Mn
Dec 31, 2025 1.76 Mn
Sep 30, 2025 7.72 Mn
Jun 30, 2025 -4.64 Mn
Mar 31, 2025 1.40 Mn
Dec 31, 2024 1.37 Mn
Sep 30, 2024 1.20 Mn
Jun 30, 2024 5.16 Mn
Mar 31, 2024 -3.29 Mn
Dec 31, 2023 5.08 Mn
Sep 30, 2023 621,000.00
Jun 30, 2023 -1.66 Mn
Mar 31, 2023 -1.37 Mn
Dec 31, 2022 3.35 Mn
Sep 30, 2022 -1.25 Mn
Jun 30, 2022 1.28 Mn
Mar 31, 2022 864,000.00
Dec 31, 2021 669,000.00
Sep 30, 2021 2.35 Mn
API Access

Galectin Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=GALT&period=max&api_key=YOUR_API_KEY